Saturday 17 October 2026
Export BGM’s income statement to Excel — free account
BGM Group Ltd.
BGM Healthcare Drug Manufacturers Specialty & Generic
BGM Group Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $37.9 million, up 51.1% from fiscal 2024.
8.65
0.06
+0.70%
Follow BGM
BGM Group Ltd. (BGM) P/E ratio
As of 16 October 2026, BGM Group Ltd. (BGM) trades at a P/E ratio of 144×. Over the past ten years it has ranged from 8.8× (April 2021) to 8,180× (June 2025); the current reading is higher than 11% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 19.2× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 5,120× | 28.16% |
| FY2024 | 3,995× | 103.05% |
| FY2023 | 1,968× | 32.27% |
| FY2022 | 1,488× | 0.00% |
| FY2021 | 1,488× | 6,891.25% |
| FY2020 | 21.3× | 0.00% |
| FY2019 | 21.3× | 0.00% |
| FY2018 | 21.3× | 0.00% |
| FY2017 | 21.3× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Mar 2023 | 108× | 117.82% |
| Sep 2022 | 49.6× | 0.00% |
| Mar 2022 | 49.6× | 0.00% |
| Sep 2021 | 49.6× | 400.62% |
| 1 more quarters | Free account |
Against its own ten years
Low 8.8×
High 8,180×
Ten-year median
1,925×
Current reading's percentile
11
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CRDL Cardiol Therapeutics Inc. compare | n/m |
| CPIX Cumberland Pharmaceuticals Inc. compare | n/m |
| DERM Journey Medical Corporation compare | n/m |
| CTOR Citius Oncology, Inc. compare | n/m |
| CLVR Clever Leaves Holdings Inc. compare | n/m |
| ORGO Organogenesis compare | n/m |
| PROCF Sofgen Pharma S.A compare | 0.1× |
| OGI Organigram Global Inc. compare | 2.0× |
| BGM BGM Group Ltd. | 144× |
| Drug Manufacturers Specialty & Generic industry median | 19.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)